Bayer (BAYRY)
(Delayed Data from OTC)
$7.96 USD
-0.03 (-0.38%)
Updated Sep 23, 2024 03:59 PM ET
2-Buy of 5 2
B Value C Growth F Momentum C VGM
Cash flow Statements
Fiscal Year End for Bayer Aktiengesellschaft falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -3,184.13 | 4,389.30 | 1,209.13 | -17,775.33 | 2,721.60 |
Depreciation/Amortization & Depletion | 10,844.65 | 6,851.56 | 3,615.55 | 15,145.76 | 6,008.80 |
Net Change from Assets/Liabilities | -4,201.49 | -2,704.59 | 1,598.37 | 10,005.41 | 1,818.88 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 381.53 | 230.72 |
Other Operating Activities | 2,079.10 | -1,063.08 | -402.25 | -2,156.66 | -1,588.16 |
Net Cash From Operating Activities | 5,538.13 | 7,473.19 | 6,020.80 | 5,600.70 | 9,191.84 |
Property & Equipment | -2,744.71 | -1,916.50 | -2,647.78 | -2,386.27 | -2,651.04 |
Acquisition/ Disposition of Subsidiaries | -707.82 | 2,315.81 | -1,592.45 | 2,180.65 | 2,392.32 |
Investments | 28.14 | -3,171.34 | 5,562.94 | 488.90 | -172.48 |
Other Investing Activities | -382.05 | 263.40 | -311.16 | -4,935.88 | -320.32 |
Net Cash from Investing Activities | -3,806.45 | -2,508.62 | 1,011.55 | -4,652.59 | -751.52 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1.08 | -10.54 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 3,520.72 | -1,026.21 | -2,900.96 | 5,102.65 | -4,811.52 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -2,574.79 | -2,091.40 | -2,357.92 | -3,161.89 | -2,928.80 |
Other Financing Activities | -1,679.73 | -1,318.05 | -1,419.72 | -1,457.58 | -1,655.36 |
Net Cash from Financing Activities | -734.88 | -4,446.19 | -6,678.60 | 483.19 | -9,395.68 |
Effect of Exchange Rate Changes | -200.23 | 121.16 | 87.55 | -282.15 | -15.68 |
Net Change In Cash & Equivalents | 796.57 | 639.54 | 441.30 | 1,149.15 | -971.04 |
Cash at Beginning of Period | 5,596.57 | 4,808.63 | 4,958.37 | 3,638.23 | 4,538.24 |
Cash at End of Period | 6,393.15 | 5,448.17 | 5,399.67 | 4,787.38 | 3,567.20 |
Diluted Net EPS | -0.81 | 1.11 | 0.30 | -3.05 | 1.17 |
Fiscal Year End for Bayer Aktiengesellschaft falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 2,127.95 | 2,173.57 | -3,184.13 | -4,662.71 | 319.49 |
Depreciation/Amortization & Depletion | 2,428.41 | 1,208.38 | 10,844.65 | 10,408.37 | 5,050.73 |
Net Change from Assets/Liabilities | -4,820.20 | -6,237.35 | -4,201.49 | -7,506.69 | -9,327.28 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 543.83 | 521.14 | 2,079.10 | 1,227.72 | 613.90 |
Net Cash From Operating Activities | 279.99 | -2,334.26 | 5,538.13 | -533.32 | -3,343.17 |
Property & Equipment | -1,047.82 | -380.00 | -2,744.71 | -1,788.24 | -1,057.69 |
Acquisition/ Disposition of Subsidiaries | -85.08 | -95.54 | -707.82 | -527.87 | -540.84 |
Investments | -91.54 | 679.65 | 28.14 | 3,252.14 | 2,627.86 |
Other Investing Activities | -1,252.44 | 124.86 | -382.05 | -536.58 | -478.69 |
Net Cash from Investing Activities | -2,476.87 | 328.97 | -3,806.45 | 399.44 | 550.65 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | -1.08 | 25.03 | 25.08 |
Issuance (Repayment) of Debt | 992.90 | 941.30 | 3,520.72 | 5,591.11 | 5,310.25 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -121.69 | 0.00 | -2,574.79 | -2,572.98 | -2,573.34 |
Other Financing Activities | -887.37 | -206.28 | -1,679.73 | -1,112.35 | -653.15 |
Net Cash from Financing Activities | -16.15 | 735.02 | -734.88 | 1,930.82 | 2,108.83 |
Effect of Exchange Rate Changes | 38.77 | -13.03 | -200.23 | -7.62 | -68.70 |
Net Change In Cash & Equivalents | -2,174.26 | -1,283.30 | 796.57 | 1,789.33 | -752.38 |
Cash at Beginning of Period | 6,361.25 | 6,413.23 | 5,596.57 | 5,628.12 | 5,638.46 |
Cash at End of Period | 4,186.99 | 5,129.93 | 6,393.15 | 7,417.45 | 4,886.08 |
Diluted Net EPS | -0.52 | 0.55 | 0.39 | -1.27 | -0.52 |